Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kristen Detweiler‐Short
Observed names:
K Detweiler-Short,
K. Detweiler-Short,
Kristen Detweiler-Short,
Kristen Detweiler-short
Observed institutions:
Mayo Clinic,
University of Michigan,
Mayo Clinic Comprehensive Cancer Center (Minnesota),
U-M Rogel Cancer Center
OpenAlex ID:
A5037265133
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
2012
·
Andrzej J. Jakubowiak
, Dominik Dytfeld
, et al.
·
Blood
·
423
PDF
Discordance between serum cardiac biomarker and immunoglobulin‐free light‐chain response in patients with immunoglobulin light‐chain amyloidosis treated with immune modulatory drugs
2010
·
Angela Dispenzieri
, David Dingli
, et al.
·
American Journal of Hematology
·
130
Efficacy of retreatment with immunomodulatory drugs (IMiDs) in patients receiving IMiDs for initial therapy of newly diagnosed multiple myeloma
2011
·
Sumit Madan
, Martha Q. Lacy
, et al.
·
Blood
·
61
Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
2014
·
D. Dytfeld
, J. Jasielec
, et al.
·
Haematologica
·
45
PDF
Long‐term results of single‐agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma
2010
·
Kristen Detweiler‐Short
, Suzanne Hayman
, et al.
·
American Journal of Hematology
·
27
Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)
2011
·
Andrzej J Jakubowiak
, Dominik Dytfeld
, et al.
·
Blood
·
24
Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up.
2013
·
Andrzej J. Jakubowiak
, Dominik Dytfeld
, et al.
·
Journal of Clinical Oncology
·
16
Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy
2011
·
S Sinha
, M Lacy
, et al.
·
Leukemia
·
12
A Phase II Study of Consolidation Treatment with Iodione-131 Tositumomab (Bexxar™) in Multiple Myeloma (MM)
2012
·
Daniel Lebovic
, Mark S. Kaminski
, et al.
·
Blood
·
8
Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma
2010
·
Sumit Madan
, Martha Lacy
, et al.
·
Blood
·
8
Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score
2010
·
Shaji Kumar
, Morie Gertz
, et al.
·
Blood
·
8
A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis
2010
·
Angela Dispenzieri
, Morie Abraham A. Gertz
, et al.
·
Blood
·
6
A Pilot Study of Pomalidomide and Dexamethasone in Previously Treated Light Chain Amyloidosis Patients.
2009
·
Angela Dispenzieri
, Morie A Gertz
, et al.
·
Blood
·
4
Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function
2010
·
Shaji Kumar
, Angela Dispenzieri
, et al.
·
Blood
·
3
A Phase III Randomized Trial of Thalidomide (THAL) Plus Zoledronic Acid (ZLD) Versus Zoledronic Acid Alone In Patients with Early Stage Multiple Myeloma (MC0289)
2010
·
Thomas E. Witzig
, Sumithra Mandrekar
, et al.
·
Blood
·
2
Stringent complete response (sCR) in patients (pts) with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX).
2012
·
Andrzej J. Jakubowiak
, Kent A. Griffith
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
17
Citation count:
777
H-index:
8
I10-index:
8
Year
Topic
Type
